About this episode
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
Get every episode summarized
Each time Chemistry in its element publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Chemistry in its element
Advances in CAR-T cancer therapy & carbon materials' hidden defects | The chemic...
Chemistry in its element
Sep 2, 202633:36pending
UK science department abolished & Ireland's crumbling concrete | The chemical br...
Chemistry in its element
Aug 19, 202631:24pending
Thermo Fisher antibody data manipulation & the shrinking chemical recycling indu...
Chemistry in its element
Aug 5, 202629:47pending
50 years after Seveso & changing the way we separate hydrocarbons | The chemical...
Chemistry in its element
Jul 22, 202634:49pending